Literature DB >> 21993448

Serial changes in plasma total cortisol, plasma free cortisol, and tissue cortisol activity in patients with septic shock: an observational study.

Jeremy Cohen1, Melissa Lassig Smith, Renae V Deans, Carel J Pretorius, Jacobus P J Ungerer, Terrence Tan, Mark Jones, Bala Venkatesh.   

Abstract

Published data on adrenocortical function in septic shock have enrolled patients at various stages of critical illness and predominantly used plasma total cortisol, with minimal information on serial changes. Moreover, plasma free cortisol and tissue corticosteroid activity may not be strongly associated; however, few published data exist. The aim of this prospective observational study was to investigate serial changes in plasma total and free cortisol and tissue cortisol activity in septic shock. Twenty-nine adult patients admitted with septic shock to a tertiary-level intensive care unit were enrolled. A low-dose corticotropin test was performed on day 1. Plasma total and free cortisol, cortisone, transcortin, and urinary free cortisol and cortisone were analyzed on days 1 to 5, 7, and 10. Urinary and plasma cortisol-cortisone ratios (F:E ratio) were calculated as indices of 11-β hydroxysteroid dehydrogenase 2 and global 11-β hydroxysteroid dehydrogenase activity, respectively. Baseline total and free plasma cortisol values from 10 healthy control subjects were obtained for comparative analysis. Baseline plasma total and free cortisol levels were significantly higher than controls (457.8 ± 193 vs. 252 ± 66 nmol/L, P = 0.0002; and 50.83 ± 43.19 vs. 6.4 ± 3.2, P < 0.0001, respectively). Plasma free cortisol rose proportionately higher than total cortisol (124% ± 217.3% vs. 40% ± 33.2%, P = 0.007) following corticotropin. Baseline plasma and urinary F:E ratios were elevated over the reference ranges (13.13 ± 1.5, 1.69 ± 2.8) and were not correlated with plasma free cortisol values (r = 0.2, 0.3 respectively). Over the study period, total cortisol levels and plasma F:E ratios remained elevated, whereas plasma free cortisol levels and urinary F:E ratio declined. At baseline, plasma free cortisol levels were higher in patients who subsequently survived (23.7 ± 10.5 vs. 57.9 ± 45.8 nmol/L, P = 0.04). In septic shock, there is a differential response of plasma total and free cortisol over time and in response to corticotropin. Changes in plasma and urinary F:E ratios suggest tissue modulation of 11-β hydroxysteroid dehydrogenase activity. Total plasma cortisol measurements may not reflect the global adrenal response in septic shock.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 21993448     DOI: 10.1097/SHK.0b013e318239b809

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  6 in total

1.  Dismissal of the utility of free cortisol measurement is premature.

Authors:  Jeremy Cohen; Carel Pretorius; Bala Venkatesh
Journal:  Intensive Care Med       Date:  2012-03-06       Impact factor: 17.440

Review 2.  Diagnosis and management of pediatric adrenal insufficiency.

Authors:  Ahmet Uçar; Firdevs Baş; Nurçin Saka
Journal:  World J Pediatr       Date:  2016-04-08       Impact factor: 2.764

Review 3.  Regulation of cortisol bioavailability--effects on hormone measurement and action.

Authors:  Ilias Perogamvros; David W Ray; Peter J Trainer
Journal:  Nat Rev Endocrinol       Date:  2012-08-14       Impact factor: 43.330

Review 4.  CIRMI-a new term for a concept worthy of further exploration: a narrative review.

Authors:  Gladness Dakalo Nethathe; Jeffrey Lipman; Ronald Anderson; Charles Feldman
Journal:  Ann Transl Med       Date:  2022-06

Review 5.  Update on adrenal insufficiency in patients with liver cirrhosis.

Authors:  Anca Trifan; Stefan Chiriac; Carol Stanciu
Journal:  World J Gastroenterol       Date:  2013-01-28       Impact factor: 5.742

6.  Dynamic pituitary-adrenal interactions in response to cardiac surgery.

Authors:  Ben Gibbison; Francesca Spiga; Jamie J Walker; Georgina M Russell; Kirsty Stevenson; Yvonne Kershaw; Zidong Zhao; David Henley; Gianni D Angelini; Stafford L Lightman
Journal:  Crit Care Med       Date:  2015-04       Impact factor: 7.598

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.